Pharmaceuticals, Biotechnology and Life Sciences
First-Quarter 2019 Worldwide Sales Were $10.8 Billion, an Increase of8%; Sales Increased 11% Excluding Negative Impact from ForeignExchange; Growth Driven by Oncology and Vaccines
First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer Biopharmaceuticals Group and…
The study provides a definition for Tumor Treating Fields dose and sets a framework for future work on Tumor Treating…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Total revenues of $498 million (+30% vs Q1 2018) and total product-related revenues of $458 million (+20% vs Q1 2018) for the…
If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV LONDON–(BUSINESS WIRE)–ViiV…
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
Seed will enable growth of the PolyProx team and furtherdevelop our technology over the next two years
Allotex has treated over 50 eyes in the first phase of its clinical trials.
DUBLIN–(BUSINESS WIRE)–The “Pharma Clinical Trial Digitization – Companies to Action, 2019” report has been added to ResearchAndMarkets.com’s offering. Despite the…